BIO-TECHNE CORP - Daily - Technical analysis published on 07/12/2019 (GMT)
- 361
- 0
- Who voted?
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
A split or consolidation has occurred on this instrument. There is no more graph available on this analysis.
Summary of the analysis
Trends
Court terme:
Neutral
De fond:
Bullish
Technical indicators
22%
28%
50%
My opinion
Bullish above 204.11 USD
My targets
215.43 USD (+3.34%)
My analysis
We are currently in a phase of short-term indecision. In a case like this, you could favour trades in the direction of the basic trend on BIO-TECHNE CORP. As long as you are above the support located at 204.11 USD, traders with an aggressive trading strategy could consider a purchase. A cross of the resistance located at 215.43 USD would be a signal that the basic trade will reverse and the short-term trend could then quickly become bullish. If the support 204.11 USD were to be broken, this would simply be a sign of a possible continuation of short-term consolidation and trading against the trend would then perhaps be more risky.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The BIO-TECHNE CORP rating is 208.47 USD. The price registered a decrease of -2.13% on the session and was traded between 208.15 USD and 212.99 USD over the period. The price is currently at +0.15% from its lowest and -2.12% from its highest.208.15
212.99
208.47
The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Near a new HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Technical
A technical analysis in Daily of this BIO-TECHNE CORP chart shows a bullish trend. The signals given by moving averages are 71.43% bullish. This bullish trend could slow down given the neutral signals currently being given by short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
On the 18 technical indicators analysed, 4 are bullish, 9 are neutral and 5 are bearish. Central Indicators, the scanner specialised in technical indicators, has identified these signals:
Pivot points : price is under support 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is under support 3
Type : Neutral
Timeframe : Daily
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
Momentum indicator is back over 0
Type : Bullish
Timeframe : Daily
No signals are given by Central Patterns, a market scanner specialised in chart patterns, resistances and supports.
There is also a Japanese candlestick pattern detected by Central Candlesticks that could mark the end of the current short-term trend:
Doji
Type : Neutral
Timeframe : Daily
ProTrendLines
S3
S2
S1
R1
Price
| S3 | S2 | S1 | Price | R1 | |
|---|---|---|---|---|---|
| ProTrendLines | 155.25 | 164.00 | 204.11 | 208.47 | 215.43 |
| Change (%) | -25.53% | -21.33% | -2.09% | - | +3.34% |
| Change | -53.22 | -44.47 | -4.36 | - | +6.96 |
| Level | Minor | Minor | Major | - | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 209.85 | 210.97 | 211.98 | 213.10 | 214.11 | 215.23 | 216.24 |
| Camarilla | 212.41 | 212.61 | 212.81 | 213.00 | 213.20 | 213.39 | 213.59 |
| Woodie | 209.81 | 210.94 | 211.94 | 213.07 | 214.07 | 215.20 | 216.20 |
| Fibonacci | 210.97 | 211.78 | 212.28 | 213.10 | 213.91 | 214.41 | 215.23 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 199.63 | 203.61 | 209.21 | 213.18 | 218.78 | 222.76 | 228.36 |
| Camarilla | 212.18 | 213.06 | 213.93 | 214.81 | 215.69 | 216.57 | 217.44 |
| Woodie | 200.45 | 204.01 | 210.02 | 213.59 | 219.60 | 223.16 | 229.17 |
| Fibonacci | 203.61 | 207.26 | 209.52 | 213.18 | 216.84 | 219.10 | 222.76 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 49.56 | |
| MACD (12,26,9): | 2.0100 | |
| Directional Movement: | -1.75 | |
| AROON (14): | 35.72 | |
| DEMA (21): | 212.60 | |
| Parabolic SAR (0,02-0,02-0,2): | 205.11 | |
| Elder Ray (13): | -0.21 | |
| Super Trend (3,10): | 200.56 | |
| Zig ZAG (10): | 208.47 | |
| VORTEX (21): | 0.9200 | |
| Stochastique (14,3,5): | 66.18 | |
| TEMA (21): | 212.56 | |
| Williams %R (14): | -50.30 | |
| Chande Momentum Oscillator (20): | 2.63 | |
| Repulse (5,40,3): | -2.6100 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | 0.1600 | |
| Courbe Coppock: | 2.43 |
| MA7: | 213.06 | |
| MA20: | 209.85 | |
| MA50: | 205.09 | |
| MA100: | 200.45 | |
| MAexp7: | 211.39 | |
| MAexp20: | 209.78 | |
| MAexp50: | 205.47 | |
| MAexp100: | 198.64 | |
| Price / MA7: | -2.15% | |
| Price / MA20: | -0.66% | |
| Price / MA50: | +1.65% | |
| Price / MA100: | +4.00% | |
| Price / MAexp7: | -1.38% | |
| Price / MAexp20: | -0.62% | |
| Price / MAexp50: | +1.46% | |
| Price / MAexp100: | +4.95% |
News
The latest news and videos published on BIO-TECHNE CORP at the time of the analysis were as follows:
- Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues
- Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland
- Bio-Techne China Recognized With "Decade of Contribution Award"
- Bio-Techne Appoints Rupert Vessey to Board of Directors
- FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis BIO-TECHNE CORP - Daily